Bioadaptives, Inc. (BDPT) Share-based Compensation (2013 - 2026)
Bioadaptives (BDPT) posted Share-based Compensation of $105000.0 for Q1 2026, little changed sequentially from $105000.0 in Q4 2025, and up 16.67% YoY from $90000.0 in Q1 2025.
Bioadaptives, Inc. (BDPT) Share-based Compensation (2013 - 2026) Analysis & Trends
Bioadaptives has reported Share-based Compensation for 12 years, with the latest figure at $105000.0 in Q1 2026.
- Quarterly Share-based Compensation rose 16.67% year-over-year to $105000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $430000.0 (up 43.87% YoY) and the FY2025 annual result came in at $443670.0, up 112.41% from the prior year.
- Share-based Compensation was little changed at $105000.0 in Q1 2026 per BDPT's latest filing, from $105000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $208871.0 in Q4 2024 and troughed at -$180000.0 in Q4 2023.
- A 4-year average of $91108.9 and a median of $105000.0 in 2025 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2024 and 2025: Share-based Compensation soared 216.04% in 2024, then tumbled 49.73% in 2025.
- Over 4 years, Share-based Compensation stood at -$180000.0 in 2023, then jumped by 216.04% to $208871.0 in 2024, then sank by 49.73% to $105000.0 in 2025, then changed by 0.0% to $105000.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $105000.0, $105000.0, and $105000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105,000.00 |
| Mar 31, 2026 | 105,000.00 |
| Dec 31, 2025 | 105,000.00 |
| Dec 31, 2025 | 105,000.00 |
| Sep 30, 2025 | 105,000.00 |
| Sep 30, 2025 | 105,000.00 |
| Jun 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 115,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Dec 31, 2024 | 208,871.00 |
| Dec 31, 2024 | 208,871.00 |
| Dec 31, 2023 | -180,000.00 |
| Dec 31, 2023 | -180,000.00 |
| Sep 30, 2023 | 180,000.00 |
| Sep 30, 2023 | 180,000.00 |
| Mar 31, 2021 | 163,900.00 |
| Mar 31, 2021 | 163,900.00 |
| Jun 30, 2020 | 10,264.00 |
| Jun 30, 2020 | 10,264.00 |